Skip to content

Effect of esketamine on infertility patients with anxiety and depression during day surgery- a prospective cohort study

Effect of esketamine on infertility patients with anxiety and depression during day surgery- a prospective cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300079078
Enrollment
Unknown
Registered
2023-12-25
Start date
2024-01-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety and depression

Interventions

Observation group (Esketamine group) :Esketamine used
Control group (non Esketamine group):Non esketamine

Sponsors

The Second Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 45 Years

Inclusion criteria

Inclusion criteria: infertile patients who underwent daytime combined exploration of the uterus and abdomen and microscopic sperm extraction for the first time, aged 25-45 years old, ASA I or II, BMI 18-30kg/m ²

Exclusion criteria

Exclusion criteria: Refusing to participate in this study; History of chronic pain; Take analgesics 24 hours before surgery; History of mental and psychological disorders; History of adverse reactions related to the treatment of Esketamine; Refusing to score on the Hospital Anxiety and Depression Scale (HADS) in a comprehensive hospital; Surgical time>4 hours; Bleeding during surgery>500 ml; Laparoscopic conversion to open surgery during surgery; (5) Those who fail to complete the HADS score or pain score.

Design outcomes

Primary

MeasureTime frame
Postoperative Anxiety and Depression Score;

Secondary

MeasureTime frame
Postoperative sleep quality;Postoperative NRS score;

Countries

China

Contacts

Public ContactWang Shizhao

The Second Hospital of Hebei Medical University

1656787846@qq.com+86 139 3315 9545

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026